Cyproheptadine Hydrochloride Tablets

About Cyproheptadine Hydrochloride Tablets

What is Cyproheptadine Hydrochloride IP?
Cyproheptadine Hydrochloride IP Tablet is a medicine that is used for the treatment of Allergies, Sneezing, Watery Eyes, Itching And Runny Nose, Loss Of Appetite, Migraine And Vascular Headache and other conditions.
Cyproheptadine Hydrochloride IP Tablet contains Cyproheptadine as an active ingredient.
Cyproheptadine Hydrochloride IP Tablet works by blocking the action of histamine.
Detailed information related to Cyproheptadine Hydrochloride IP Tablet uses, composition, dosage, side effects and reviews is listed below.

Cyproheptadine Hydrochloride IP Tablet Uses
Cyproheptadine Hydrochloride IP Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:

• Allergies
• Sneezing
• Watery Eyes
• Itching And Runny Nose
• Loss Of Appetite
• Migraine And Vascular Headache

Cyproheptadine Hydrochloride IP Tablet Working, Mechanism of Action and Pharmacology
Cyproheptadine Hydrochloride IP Tablet improves the patient's condition by performing the following functions:

• Blocking the action of histamine.

Cyproheptadine Hydrochloride IP Tablet Composition and Active Ingredients
Cyproheptadine Hydrochloride IP Tablet is composed of the following active ingredients (salts)

• Cyproheptadine (4 MG)

Please note that this medicine may be available in various strengths for each active ingredient listed above.

Cyproheptadine Hydrochloride IP Tablet Side-effects
The following is a list of possible side effects that may occur from all constituting ingredients of Cyproheptadine Hydrochloride IP Tablet. This is not a comprehensive list. These side effects are possible, but do not always occur. Some of the side effects may be rare but serious. Consult your doctor if you observe any of the following side effects, especially if they do not go away.

• Disturbed Coordination
• Restlessness
• Irritability
• Blurred Vision
• Inflammation Of Nerves
• Nausea

Cyproheptadine Hydrochloride IP Tablet Precautions & How to Use
Before using this drug, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.

• Avoid drinking alcohol as it can increase certain side effects
• Consult your doctor before taking this medicine if you are pregnant
• Do not start or continue the drug without consulting
• Do not take this medicine while you are breastfeeding
• If you are allergic to it or any of the other ingredients
• If you are taking other medicines such as antihistamines or monoamine-oxidase inhibitors

Additional Information

The most widely recognized markets for this item incorporate the accompanying nations.you don't mind ask with us if your nation or district isn't recorded:

ASIA:Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth.

AFRICA:South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , and so forth.

NORTH & SOUTH AMERICA:USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, and so forth .

EUROPE:Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.

OCEANIA:Australia, New Zealand, Fiji, and so forth.